Literature DB >> 18094365

Mechanisms of vascular calcification in chronic kidney disease.

Sharon M Moe1, Neal X Chen.   

Abstract

Vascular calcification is common in chronic kidney disease and associated with increased morbidity and mortality. Its mechanism is multifactorial and incompletely understood. Patients with chronic kidney disease are at risk for vascular calcification because of multiple risk factors that induce vascular smooth muscle cells to change into a chondrocyte or osteoblast-like cell; high total body burden of calcium and phosphorus due to abnormal bone metabolism; low levels of circulating and locally produced inhibitors; impaired renal excretion; and current therapies. Together these factors increase risk and complicate the management of vascular calcification.

Entities:  

Mesh:

Year:  2007        PMID: 18094365     DOI: 10.1681/ASN.2007080854

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  142 in total

1.  Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis.

Authors:  Su-Li Cheng; Jian-Su Shao; Linda R Halstead; Kathryn Distelhorst; Oscar Sierra; Dwight A Towler
Journal:  Circ Res       Date:  2010-05-20       Impact factor: 17.367

Review 2.  The dualistic role of vitamin D in vascular calcifications.

Authors:  M Shawkat Razzaque
Journal:  Kidney Int       Date:  2010-10-20       Impact factor: 10.612

Review 3.  Pathophysiology of Vascular Calcification.

Authors:  Neal X Chen; Sharon M Moe
Journal:  Curr Osteoporos Rep       Date:  2015-12       Impact factor: 5.096

Review 4.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

5.  Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB.

Authors:  Jakob Voelkl; Rashad Tuffaha; Trang T D Luong; Daniel Zickler; Jaber Masyout; Martina Feger; Nicolas Verheyen; Florian Blaschke; Makoto Kuro-O; Andreas Tomaschitz; Stefan Pilz; Andreas Pasch; Kai-Uwe Eckardt; Juergen E Scherberich; Florian Lang; Burkert Pieske; Ioana Alesutan
Journal:  J Am Soc Nephrol       Date:  2018-04-13       Impact factor: 10.121

6.  CKD-mineral and bone disorder: core curriculum 2011.

Authors:  Ranjani N Moorthi; Sharon M Moe
Journal:  Am J Kidney Dis       Date:  2011-10-21       Impact factor: 8.860

7.  A rat model of chronic kidney disease-mineral bone disorder.

Authors:  Sharon M Moe; Neal X Chen; Mark F Seifert; Rachel M Sinders; Dana Duan; Xianming Chen; Yun Liang; J Scott Radcliff; Kenneth E White; Vincent H Gattone
Journal:  Kidney Int       Date:  2008-09-17       Impact factor: 10.612

8.  Biomarkers of vascular calcification and mortality in patients with ESRD.

Authors:  Julia J Scialla; W H Linda Kao; Ciprian Crainiceanu; Stephen M Sozio; Pooja C Oberai; Tariq Shafi; Josef Coresh; Neil R Powe; Laura C Plantinga; Bernard G Jaar; Rulan S Parekh
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

9.  Quantifying a rare disease in administrative data: the example of calciphylaxis.

Authors:  Sagar U Nigwekar; Craig A Solid; Elizabeth Ankers; Rajeev Malhotra; William Eggert; Alexander Turchin; Ravi I Thadhani; Charles A Herzog
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

10.  No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.

Authors:  Rajnish Mehrotra; Carmen A Peralta; Shu-Cheng Chen; Suying Li; Michael Sachs; Anuja Shah; Keith Norris; Georges Saab; Adam Whaley-Connell; Bryan Kestenbaum; Peter A McCullough
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.